PDCD1 and type 2 diabetes mellitus: Findings from pathway analysis show that drugs from five drug classes (JAKis, interferons, PD-1/PD-L1 inhibitors, selective immunosuppressants, and aminoquinolines) are involved in enriched pathways in the genes related to instruments for SBP, DBP, WHR, and T2DM.